Oct 16,2017

Tandem Diabetes Care Schedules Third Quarter 2017 Earnings Press Release and Conference Call

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, plans to release its third quarter 2017 results after the financial markets close on Thursday, October 26, 2017. The Company will hold a conference call and simultaneous webcast on the same day at 4:30pm Eastern Time (1:30pm Pacific Time), to discuss its third quarter 2017 financial and operating results.

View Analyst & Ambassador Comments
Go to original news
Oct 17,2017

One Drop Announces “Revive” Digital Weight Loss And Diabetes Prevention Program

One Drop today announced the Centers for Disease Control and Prevention (CDC) have awarded Pending Recognition to its newest addition to the One Drop | Experts education platform: Revive. Revive is a 12-month weight loss and diabetes prevention program (“DPP”) based on the PreventT2 curriculum, which helps people lose 5 to 7% of their body weight, increase their physical activity, and prevent or delay the onset of type 2 diabetes.

PRODUCT

#coaching

View Analyst & Ambassador Comments
Go to original news
Oct 18,2017

DarioHealth Gains CE Mark for iPhone 7 and iPhone 8 Smart Glucose Meter

DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, announced today that it received the CE Mark for its Lightning®-enabled version of the acclaimed Dario™ Blood Glucose Monitoring System. The news ensures that consumers, beginning in the UK market, will be able to receive the same quality user experience with DarioHealth on the latest Apple devices, including the brand-new iPhone 8.

REGULATORY CE MARK

#bgm

View Analyst & Ambassador Comments
Go to original news
Oct 18,2017

Insulet and Dexcom Partner to Offer Choices for Animas Users

Insulet Corporation is partnering with DexCom, Inc. to provide the Omnipod System and a $200 gift card from Dexcom which can be used towards the purchase of a Dexcom G5 Mobile CGM for qualified Animas insulin pump users.

COLLABORATION PARTNERSHIP

#product & service

#insulin pump

#cgm

View Analyst & Ambassador Comments
Go to original news
Oct 24,2017

Tandem Diabetes Care to Provide All t:slim X2 Insulin Pump Features Approved in 2018 to Users at No Cost and Expands Existing Dexcom Welcome Offer for Animas Customers

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, today announced that it will make any new features approved for the t:slim X2™ Insulin Pump by the U.S. Food and Drug Administration (FDA) in 2018 available to all in-warranty users at no cost through the Tandem Device Updater. Tandem and continuous glucose monitoring partner, Dexcom, Inc., also announced the extension of their existing joint welcome program for Animas customers from December 31, 2017 to March 31, 2018.

PRODUCT

#insulin pump

#cgm

View Analyst & Ambassador Comments
Go to original news
Oct 26,2017

Tandem Diabetes Care Reports Third Quarter 2017 Financial Results

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, today reported its financial results for the quarter ended September 30, 2017. The Company's GAAP sales were $27.0 million for the quarter ended September 30, 2017 compared to $12.3 million for the same period of 2016. A total of 3,868 pumps were shipped in the third quarter of 2017 compared to 3,896 in the third quarter of 2016.

View Analyst & Ambassador Comments
Go to original news
Oct 30,2017

Senseonics to Present at the Canaccord Genuity Medical Technologies & Diagnostics Forum

Senseonics Holdings, Inc. (NYSE American: SENS) today announced the company plans to participate in the Canaccord Genuity Medical Technologies & Diagnostics Forum in New York, NY. Senseonics’ management is scheduled to present on Thursday, November 9, 2017 at 11:00 AM ET.

CONFERENCES
View Analyst & Ambassador Comments
Go to original news
Oct 30,2017

DarioHealth Expanding its Mobile Health and Data Offerings to Include a Business-to-Business Solution

DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, announced today that it is increasing its B2B2C offering by facilitating organizations to digitize targeted healthcare solutions in patients with diabetes. The strategic move comes on the eve of Diabetes Awareness Month, and DarioHealth has officially launched its new corporate website http://www.dariohealth.com to showcase its first-class capabilities.

View Analyst & Ambassador Comments
Go to original news
Oct 30,2017

Brighter strengthens its financing with 5.3 MSEK through exercise of warrants.

The first exercise period for Brighter’s warrants of series TO3 is now completed. The company thereby strengthens its financing with 5.3 MSEK, representing a subscription rate of 20 % and 1,332,198 new shares.

View Analyst & Ambassador Comments
Go to original news
Oct 31,2017

One Drop Partners with Fitbit to Bring Diabetes Management Data Insights to Users Worldwide

One Drop, a leading digital diabetes care and self-management platform, today announced a multi-part collaboration with Fitbit (NYSE: FIT) that will use the power of Fitbit wearable data to bring enhanced data-driven care management tools to the diabetes community. The first initiative will be to integrate enhanced access to Fitbit data into the One Drop | Mobile app for diabetes management, providing One Drop users with at-a-glance access to Fitbit data, with the goal of helping users better understand the impact of physical activity on blood glucose management.

COLLABORATION PARTNERSHIP

#connected device

#mobile app

View Analyst & Ambassador Comments
Go to original news
Subscribe to DIABETES